National Peroxide Share Price

  • 577.108.45 (1.48%)
  • Volume: 550
BSE
  • Closed
  • Last Updated On: 09 May, 2025, 03:58 PM IST
Loading...
National Peroxide Share Price
  • 577.108.45 (1.48%)
  • Volume: 550
Advertisment

National Peroxide share price insights

  • Company has spent less than 1% of its operating revenues towards interest expenses and 10.56% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

  • National Peroxide Ltd. share price moved up by 1.48% from its previous close of Rs 568.65. National Peroxide Ltd. stock last traded price is 577.10

    Share PriceValue
    Today/Current/Last-577.10
    Previous Day-568.65

InsightsNational Peroxide

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    -147.65
    EPS - TTM
    (₹)
    -3.91
    MCap
    (₹ Cr.)
    331.66
    Sectoral MCap Rank
    188
    PB Ratio
    (x)
    0.94
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month-
    3 Months-
    6 Months-
    1 Year-
    3 Years-
    -
    VWAP
    (₹)
    570.19
    52W H/L
    (₹)
    1,418.05 / 552.00

    National Peroxide Share Price Returns

    1 Day1.48%
    1 Week0.13%
    1 Month-2.19%
    3 Months-19.09%
    1 YearN.A.
    3 YearsN.A.
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether National Peroxide belongs to analysts' top-rated companies list?

    View Stock Screeners

    National Peroxide Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    National Peroxide Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    National Peroxide Financials

    • Insights

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 10.56% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income73.7162.5279.2275.9188.46
      Total Income Growth (%)17.89-21.084.37-14.204.21
      Total Expenses81.1464.1377.8868.6383.86
      Total Expenses Growth (%)26.53-17.6613.49-18.176.08
      EBIT-7.43-1.601.347.284.60
      EBIT Growth (%)--219.37-81.5758.25-21.15
      Profit after Tax (PAT)-6.49-1.520.685.083.07
      PAT Growth (%)--323.68-86.6465.50-35.60
      EBIT Margin (%)-10.08-2.561.699.595.20
      Net Profit Margin (%)-8.81-2.430.866.703.47
      Basic EPS (₹)-11.29-2.641.188.855.35
      Quarterly | Annual FY 2025 FY 2024 FY 2023
      Total Revenue291.36338.15384.73
      Total Revenue Growth (%)-13.84-12.11-
      Total Expenses293.44316.64344.18
      Total Expenses Growth (%)-7.33-8.000.41
      Profit after Tax (PAT)-2.2516.7939.50
      PAT Growth (%)-113.38-57.49-
      Operating Profit Margin (%)-0.147.0512.65
      Net Profit Margin (%)-0.785.0410.50
      Basic EPS (₹)-3.9129.2268.73

      All figures in Rs Cr, unless mentioned otherwise

      No reported Profit & Loss Statement are available.

    • Annual FY 2025 FY 2024 FY 2023
      Total Assets441.72459.33453.55
      Total Assets Growth (%)-3.831.27-
      Total Liabilities92.46100.36101.55
      Total Liabilities Growth (%)-7.87-1.170.10
      Total Equity349.27358.96351.99
      Total Equity Growth (%)-2.701.98-
      Current Ratio (x)3.302.942.80
      Total Debt to Equity (x)0.010.030.04
      Contingent Liabilities0.000.194.62

      All figures in Rs Cr, unless mentioned otherwise

      No reported Balance Sheet are available.

    • Insights

      • Decrease in Cash from Investing

        Company has used Rs 1.73 cr for investing activities which is an YoY decrease of 90.14%. (Source: Standalone Financials)
      Annual FY 2025 FY 2024 FY 2023
      Net Cash flow from Operating Activities18.6736.4067.11
      Net Cash used in Investing Activities-1.73-17.5124.79
      Net Cash flow from Financing Activities-12.54-16.72-85.96
      Net Cash Flow4.322.186.42
      Closing Cash & Cash Equivalent12.938.616.43
      Closing Cash & Cash Equivalent Growth (%)50.1733.940.03
      Total Debt/ CFO (x)0.190.290.21

      All figures in Rs Cr, unless mentioned otherwise

      No reported Cash Flow Statement are available.

    • Annual FY 2025 FY 2024 FY 2023
      Return on Equity (%)-0.644.6711.22
      Return on Capital Employed (%)-0.105.6111.51
      Return on Assets (%)-0.503.658.70
      Interest Coverage Ratio (x)11.8321.589.60
      Asset Turnover Ratio (x)0.640.731.66
      Price to Earnings (x)-149.25--
      Price to Book (x)0.95--
      EV/EBITDA (x)15.81--
      EBITDA Margin (%)6.8612.8317.92

      No reported Financial Ratios are available.

    Financial InsightsNational Peroxide

    • Income (P&L)
    • Cash Flow
      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 10.56% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

      • Decrease in Cash from Investing

        Company has used Rs 1.73 cr for investing activities which is an YoY decrease of 90.14%. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    National Peroxide Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    National Peroxide Peer Comparison

      • There’s no suggested peer for this stock.
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      National Peroxide Ltd.-147.650.95-0.64-0.10-0.500.00-0.14-0.78-3.913.300.010.19
      Add More stocks of your interest to compare.
      Annual Ratios (%)

      Choose from Peers

        Choose from Stocks

        Peers InsightsNational Peroxide

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          National Peroxide Shareholding Pattern

          • Loading...
            Showing National Peroxide Shareholding as on Mar 2025
            CategoryMar 2025Dec 2024Sep 2024Jun 2024
            Promoters70.7670.7670.7670.76
            Pledge0.000.000.000.00
            FII0.000.000.000.07
            DII0.000.000.000.00
            Mutual Funds0.000.000.000.00
            Others29.2329.2329.2329.17
          • Showing Shareholding as on Mar 2025
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters40,66,65970.76 %0.00
            Pledge00.00 %0.00
            FII4,0740.07 %-
            Others16,76,26729.23 %0.00

          National Peroxide MF Ownership

          MF Ownership details are not available.

          National Peroxide Corporate Actions

          • Meeting DateAnnounced onPurposeDetails
            May 06, 2025May 02, 2025Board MeetingAudited Results & Dividend
            Jan 23, 2025Jan 17, 2025Board MeetingQuarterly Results
            Oct 29, 2024Oct 24, 2024Board MeetingQuarterly Results
            Aug 27, 2024Jul 31, 2024AGMBook closure from Aug 21, 2024 to Aug 27, 2024
            Jul 31, 2024Jul 24, 2024Board MeetingQuarterly Results
          • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
            Final125%12.5Aug 20, 2024May 09, 2024
          • No other corporate actions details are available.

          About National Peroxide

          • Executives

          • Auditors

          • NN

            Ness Nusli Wadia

            Chairman, Non Ind & Non Exe Director
            RA

            Rajiv Arora

            Director & CEO
            MB

            Minnie Bodhanwala

            Non Exe.Non Ind.Director
            JS

            Jaivir Singh

            Ind. Non-Executive Director
            Show More
          • Kalyaniwalla & Mistry LLP

          Trending in Markets

          Top Gainers As on 03:59 PM | 09 May 2025

          KPR Mill1,306.25
          117.41 (9.88%)
          YES Bank20.02
          1.79 (9.82%)
          Welspun India146.90
          9.02 (6.54%)
          Craftsman Automation4,867.50
          290.40 (6.35%)
          Union Bank India122.90
          7.33 (6.34%)

          Top Losers As on 03:59 PM | 09 May 2025

          Sonata Software365.70
          -26.91 (-6.86%)
          Chola Fin Holdings1,718.00
          -111.00 (-6.07%)
          MCX India5,670.50
          -334.00 (-5.57%)
          Poly Medicure2,526.80
          -148.00 (-5.54%)
          Raymond1,456.20
          -84.21 (-5.47%)

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          The Economic Times